Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Alpa Laboratories Limited
ALPA | NSE
51.75
INR1.54
3.07%
ALPA | NSE
Loading StockChartView...
About Alpa Laboratories Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
02/04/2026
Close
51.75
Open
50.17
High
54.50
Low
48.60
Alpa Laboratories Limited engages in manufacturing and selling pharmaceutical finished dosage forms in India. It offers ethical generic and over the counter products in various finished dosage forms including injections tablets capsules eye and ear drops ointments creams and gels for human use. The company also provides boluses injections and intra-mammary infusions for veterinary use. In addition the company provides drugs in various categories such as anti-infectives comprising antibacterial antibiotics antifungals antiprotozoals and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations as well as ear and eye care preparations. It sells its products through distributors retail chemists retail pharmacy stores and hospitals. The company also exports its products to South and Central America Africa and Asia and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore India.
View LessALPA | NSE
Risk
61.8
Sharpe
-1.48
Luna's Score
45/100
Recommendation
Sell
Luna says (ALPA | NSE)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
92.4%1 month
61.8%3 months
50.2%6 months
45.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
13.54
Fwd. PE
-
Price to book
1.64
Debt to equity
0.03
Debt to assets
0.03
Ent. to EBITDA
7.06
Ent. to rev.
1.50
PEG
-
Other Fundamentals
EBITDA
77.45M
MarketCap
1.09B
MarketCap(USD)
11.78M
Div. yield
-
Op. margin
-0.06
Erngs. growth
68.10
Rev. growth
-15.70
Ret. on equity
11.71
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
16.34
Range1M
18.90
Range3M
33.98
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.39
Price X volume
2.01M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 7.06 | 24.85 | Cheaper |
| Ent. to Revenue | 1.50 | 11.40 | Cheaper |
| PE Ratio | 13.54 | 51.36 | Cheaper |
| Price to Book | 1.64 | 6.83 | Cheaper |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 50.23 | 42.17 | Par |
| Debt to Equity | 0.03 | 0.35 | Cheaper |
| Debt to Assets | 0.03 | 0.17 | Cheaper |
| Market Cap | 1.09B | 290.82B | Emerging |
